Trial Profile
68GA-PSMA Fusion PET/MRI For Image-Guided Prostate Biopsies
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 19 Aug 2021 Status changed from recruiting to discontinued due to pandemic related constraints.
- 15 Nov 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 15 Oct 2018 to 15 Dec 2018.
- 05 Oct 2018 New trial record